M.D. Minden
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Cancer, Lipids, and Metabolism
Papers in
- Hematology 11
- Acute Myeloid Leukemia Research 10
- Chronic Myeloid Leukemia Treatments 3
-
- Glycosylation and Glycoproteins Research 1
- Peroxisome Proliferator-Activated Receptors 1
- Co-authors
- E. A. McCulloch (6 shared papers)Linda Z. Penn (1 shared paper)Zhenlei Xia (1 shared paper)Guisheng Yang (2 shared papers)W. Wei‐Lynn Wong (1 shared paper)Zhenbo Hu (2 shared papers)Freda K. Stevenson (1 shared paper)Hassan Jumaa (1 shared paper)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (2 papers)Leukemia Research (2 papers)Stem Cells (1 paper)HemaSphere (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
M.D. Minden
15 papers receiving 295 citations
Peers
Comparison fields: 5 of 55
- Hematology 85
- Cancer Research 84
- Genetics 24
- Molecular Biology 152
- Immunology 43
Countries citing papers authored by M.D. Minden
This map shows the geographic impact of M.D. Minden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.D. Minden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.D. Minden more than expected).
Fields of papers citing papers by M.D. Minden
This network shows the impact of papers produced by M.D. Minden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.D. Minden. The network helps show where M.D. Minden may publish in the future.
Co-authors
The 25 scholars most cited alongside M.D. Minden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 115 | |
| 2 | 2015 | 60 | |
| 3 | Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. | 1995 | 50 |
| 4 | Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. | 1994 | 31 |
| 5 | Regulation of the synthesis of bcl-2 protein by growth factors. | 1996 | 17 |
| 6 | The influence of growth regulation on treatment strategy for acute myeloblastic leukaemia. | 1990 | 7 |
| 7 | 2003 | 6 | |
| 8 | High-dose cytosine arabinoside remission induction for acute myelogenous leukemia: comparison of two regimens of remission maintenance. | 1992 | 6 |
| 9 | 1986 | 5 | |
| 10 | 2009 | 2 | |
| 11 | 2004 | 2 | |
| 12 | 2019 | 1 | |
| 13 | 2009 | 1 | |
| 14 | 2017 | 1 | |
| 15 | 2010 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2009 | 0 | |
| 18 | 2009 | 0 |
About M.D. Minden
M.D. Minden is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Oncology, having authored 18 papers that have together received 306 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Galectins and Cancer Biology (1 paper) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Hematology (85 citations), Cancer Research (84 citations), Genetics (24 citations), Molecular Biology (152 citations) and Immunology (43 citations). M.D. Minden has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include E. A. McCulloch, Linda Z. Penn, Zhenlei Xia, Guisheng Yang, W. Wei‐Lynn Wong, Zhenbo Hu, Freda K. Stevenson, Hassan Jumaa, Cornelis A.M. van Bergen and Sergey Krysov. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Stem Cells and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.